CHARLES AMPADU: Open Payments
NPI 1962545269 · SWANSEA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,373 in 76 payments from 25 companies in 2025. Trend: 2023 $1,583 · 2024 $1,481 · 2025 $1,373
Food & beverage: $1,373
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $201 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Lilly USA, LLC | 4 | $84 |
| Lundbeck LLC | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| SANOFI-AVENTIS U.S. LLC | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Novo Nordisk Inc | 3 | $57 |
Products named: REXULTI, AUSTEDO XR, Kerendia, TZIELD, SPRAVATO, COBENFY, Ohtuvayre, Auvelity.
Industry payments across IL — which companies pay providers there.
